Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study

Title:	Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study
Authors:	Marini, Irene^Aff1; Giunta, Emilio Francesco^Aff2; Nicolini, Silvia^{Aff1, IDs0025902507661w_cor1}; Grassi, Ilaria^Aff1; Foca, Flavia^Aff3; Sarnelli, Anna^Aff4; Di Iorio, Valentina^Aff5; Vizza, Lilla^Aff3; Giani, Erika^Aff3; Celli, Monica^Aff1; Monti, Manuela^Aff3; Severi, Stefano^Aff1; De Giorgi, Ugo^Aff2; Borgia, Francesca^Aff6; Paganelli, Giovanni^Aff1; Matteucci, Federica^Aff1; Sansovini, Maddalena^Aff1
Source:	European Journal of Nuclear Medicine and Molecular Imaging. 53(5):3023-3033
Database:	Springer Nature Journals